Safioleas M, Stamatakos M, Karampali E, Rompoti N, Mouzopoulos G, Lygidakis N
2nd Department of Propedeutic Surgery, University of Athens, School of Medicine, Laiko General Hospital, Greece.
Chirurgia (Bucur). 2006 Mar-Apr;101(2):121-6.
Medullary thyroid carcinoma (MTC) is a rare and particularly aggressive type of thyroid cancer with several distinctive features that distinguish its management from other thyroid cancers. Since MTC was first recognised as a distinct tumour in 1959, it became clear that MTC is more difficult to cure than differentiated thyroid cancer and has higher rates of recurrence and mortality, but it is usually a slow growing tumor compared with other malignancies. In addition, unlike differentiated thyroid cancer, there is no known effective systemic therapy for MTC.
甲状腺髓样癌（MTC）是一种罕见且侵袭性特别强的甲状腺癌，具有几个独特的特征，使其治疗方法有别于其他甲状腺癌。自1959年MTC首次被确认为一种独特的肿瘤以来，很明显MTC比分化型甲状腺癌更难治愈，复发率和死亡率更高，但与其他恶性肿瘤相比，它通常是一种生长缓慢的肿瘤。此外，与分化型甲状腺癌不同，目前尚无已知对MTC有效的全身治疗方法。
